Medpace Holdings Inc [MEDP] stock is trading at $477.73, up 54.67%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MEDP shares have gain 52.77% over the last week, with a monthly amount glided 54.43%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medpace Holdings Inc [NASDAQ: MEDP] stock has seen the most recent analyst activity on June 24, 2025, when Barclays initiated its Equal Weight rating and assigned the stock a price target of $300. Previously, William Blair downgraded its rating to Mkt Perform on April 22, 2025. On April 14, 2025, downgrade downgraded it’s rating to Hold but maintained its price target of $328 on the stock. Leerink Partners started tracking the stock assigning a Market Perform rating and suggested a price target of $330 on March 24, 2025. Robert W. Baird downgraded its rating to a Neutral and reduced its price target to $349 on October 23, 2024. In a note dated September 27, 2024, UBS downgraded an Neutral rating on this stock and revised its target price from $420 to $350.
Medpace Holdings Inc [MEDP] stock has fluctuated between $250.05 and $440.38 over the past year. Currently, Wall Street analysts expect the stock to reach $330 within the next 12 months. Medpace Holdings Inc [NASDAQ: MEDP] shares were valued at $477.73 at the most recent close of the market. An investor can expect a potential drop of -30.92% based on the average MEDP price forecast.
Analyzing the MEDP fundamentals
Medpace Holdings Inc [NASDAQ:MEDP] reported sales of 2.23B for the trailing twelve months, which represents a growth of 14.24%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.27, Equity is 0.68 and Total Capital is 1.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 442.06 points at the first support level, and at 406.39 for the second support level. However, for the 1st resistance point, the stock is sitting at 507.35, and for the 2nd resistance point, it is at 536.97.
Ratios To Look Out For
For context, Medpace Holdings Inc’s Current Ratio is 0.43. As well, the Quick Ratio is 0.73, while the Cash Ratio is 0.04. Considering the valuation of this stock, the price to sales ratio is 6.15, the price to book ratio is 77.66 and price to earnings (TTM) ratio is 35.52.
Transactions by insiders
Recent insider trading involved DAVENPORT FRED B JR, Director, that happened on Apr 24 ’25 when 1712.0 shares were sold. Director, DAVENPORT FRED B JR completed a deal on Apr 24 ’25 to buy 1712.0 shares. Meanwhile, General Counsel & Corp. Secy. EWALD STEPHEN P bought 2.0 shares on Feb 27 ’25.
